Top

Reactions Weekly

Published in:

01-08-2023 | Sunitinib | Case report

Sunitinib

Cardiomyopathy following off-label use: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Lindhauer C, et al. Sunitinib in Kombination mit intensiver Salvage-Chemotherapie bei Patienten mit FLT3-mutierter rezidivierter oder refraktarer AML nach Standardtherapie mit intensiver Chemotherapie und Midostaurin -eine Fallserie. Oncology Research and Treatment 45 (Suppl. 2): 95 abstr. P326, 2022. Available from: URL: https://doi.org/10.1159/000526456 [abstract]

Title: Sunitinib
Cardiomyopathy following off-label use: case report
Publication date: 01-08-2023
Publisher: Springer International Publishing
Keywords: Sunitinib
Acute Myeloid Leukemia
Cardiomyopathy
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-45365-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Sunitinib

Cardiomyopathy following off-label use: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Immunosuppressants/immune globulin

Lorlatinib

Vildagliptin

Cephalosporins/nitrofurantoin

Cabozantinib/nivolumab

Upadacitinib